165 related articles for article (PubMed ID: 28268212)
1. Inhibition of Ceramide Decreased the Expression of ATP-Binding Cassette Transporter G5/8 mRNA in an Animal Model of Cholesterol Gallstone.
Kim HJ; Kim JS; Oh S; Yoo HS
Dig Dis; 2017; 35(5):439-443. PubMed ID: 28268212
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in ABCG5/G8 transporters linked to hypercholesterolemia and gallstone disease.
Rudkowska I; Jones PJ
Nutr Rev; 2008 Jun; 66(6):343-8. PubMed ID: 18522623
[TBL] [Abstract][Full Text] [Related]
3. Increased gallstone risk in humans conferred by common variant of hepatic ATP-binding cassette transporter for cholesterol.
Grünhage F; Acalovschi M; Tirziu S; Walier M; Wienker TF; Ciocan A; Mosteanu O; Sauerbruch T; Lammert F
Hepatology; 2007 Sep; 46(3):793-801. PubMed ID: 17626266
[TBL] [Abstract][Full Text] [Related]
4. Hepatic expression of ABC transporters G5 and G8 does not correlate with biliary cholesterol secretion in liver transplant patients.
Geuken E; Visser DS; Leuvenink HG; de Jong KP; Peeters PM; Slooff MJ; Kuipers F; Porte RJ
Hepatology; 2005 Nov; 42(5):1166-74. PubMed ID: 16250035
[TBL] [Abstract][Full Text] [Related]
5. FMO3 and its metabolite TMAO contribute to the formation of gallstones.
Chen Y; Weng Z; Liu Q; Shao W; Guo W; Chen C; Jiao L; Wang Q; Lu Q; Sun H; Gu A; Hu H; Jiang Z
Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2576-2585. PubMed ID: 31251986
[TBL] [Abstract][Full Text] [Related]
6. Alteration of the expression of adenosine triphosphate-binding cassette transporters associated with bile acid and cholesterol transport in the rat liver and intestine during cholestasis.
Kamisako T; Ogawa H
J Gastroenterol Hepatol; 2005 Sep; 20(9):1429-34. PubMed ID: 16105132
[TBL] [Abstract][Full Text] [Related]
7. Proteasome inhibition protects against diet-induced gallstone formation through modulation of cholesterol and bile acid homeostasis.
Lee EJ; Kim MH; Kim YR; Park JW; Park WJ
Int J Mol Med; 2018 Mar; 41(3):1715-1723. PubMed ID: 29286073
[TBL] [Abstract][Full Text] [Related]
8. Impact of a high-cholesterol diet on expression levels of Niemann-Pick C1-like 1 and intestinal transporters in rats and mice.
Kawase A; Araki Y; Ueda Y; Nakazaki S; Iwaki M
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):457-63. PubMed ID: 25716431
[TBL] [Abstract][Full Text] [Related]
9. Evidence that the adenosine triphosphate-binding cassette G5/G8-independent pathway plays a determinant role in cholesterol gallstone formation in mice.
Wang HH; Li X; Patel SB; Wang DQ
Hepatology; 2016 Sep; 64(3):853-64. PubMed ID: 27014967
[TBL] [Abstract][Full Text] [Related]
10. Expression and regulation of the sterol half-transporter genes ABCG5 and ABCG8 in rats.
Dieter MZ; Maher JM; Cheng X; Klaassen CD
Comp Biochem Physiol C Toxicol Pharmacol; 2004 Dec; 139(4):209-18. PubMed ID: 15683829
[TBL] [Abstract][Full Text] [Related]
11. The ABCG5/8 cholesterol transporter and myocardial infarction versus gallstone disease.
Stender S; Frikke-Schmidt R; Nordestgaard BG; Tybjærg-Hansen A
J Am Coll Cardiol; 2014 May; 63(20):2121-2128. PubMed ID: 24657701
[TBL] [Abstract][Full Text] [Related]
12. ABCG5/ABCG8 in cholesterol excretion and atherosclerosis.
Yu XH; Qian K; Jiang N; Zheng XL; Cayabyab FS; Tang CK
Clin Chim Acta; 2014 Jan; 428():82-8. PubMed ID: 24252657
[TBL] [Abstract][Full Text] [Related]
13. Scavenger receptor class B type I mediates biliary cholesterol secretion independent of ATP-binding cassette transporter g5/g8 in mice.
Wiersma H; Gatti A; Nijstad N; Oude Elferink RP; Kuipers F; Tietge UJ
Hepatology; 2009 Oct; 50(4):1263-72. PubMed ID: 19637290
[TBL] [Abstract][Full Text] [Related]
14. Piperine prevents cholesterol gallstones formation in mice.
Song XY; Xu S; Hu JF; Tang J; Chu SF; Liu H; Han N; Li JW; Zhang DM; Li YT; Chen NH
Eur J Pharmacol; 2015 Mar; 751():112-7. PubMed ID: 25645812
[TBL] [Abstract][Full Text] [Related]
15. Relation between hepatic expression of ATP-binding cassette transporters G5 and G8 and biliary cholesterol secretion in mice.
Kosters A; Frijters RJ; Schaap FG; Vink E; Plösch T; Ottenhoff R; Jirsa M; De Cuyper IM; Kuipers F; Groen AK
J Hepatol; 2003 Jun; 38(6):710-6. PubMed ID: 12763362
[TBL] [Abstract][Full Text] [Related]
16. Significant association of ABCG5 604Q and ABCG8 D19H polymorphisms with gallstone disease.
Kuo KK; Shin SJ; Chen ZC; Yang YH; Yang JF; Hsiao PJ
Br J Surg; 2008 Aug; 95(8):1005-11. PubMed ID: 18457353
[TBL] [Abstract][Full Text] [Related]
17. Reduced susceptibility to cholesterol gallstone formation in mice that do not produce apolipoprotein B48 in the intestine.
Wang HH; Wang DQ
Hepatology; 2005 Oct; 42(4):894-904. PubMed ID: 16175613
[TBL] [Abstract][Full Text] [Related]
18. Abcg5/Abcg8-independent pathways contribute to hepatobiliary cholesterol secretion in mice.
Plösch T; van der Veen JN; Havinga R; Huijkman NC; Bloks VW; Kuipers F
Am J Physiol Gastrointest Liver Physiol; 2006 Sep; 291(3):G414-23. PubMed ID: 16614371
[TBL] [Abstract][Full Text] [Related]
19. Liver-specific induction of Abcg5 and Abcg8 stimulates reverse cholesterol transport in response to ezetimibe treatment.
Altemus JB; Patel SB; Sehayek E
Metabolism; 2014 Oct; 63(10):1334-41. PubMed ID: 25060694
[TBL] [Abstract][Full Text] [Related]
20. Genetic and functional identification of the likely causative variant for cholesterol gallstone disease at the ABCG5/8 lithogenic locus.
von Kampen O; Buch S; Nothnagel M; Azocar L; Molina H; Brosch M; Erhart W; von Schönfels W; Egberts J; Seeger M; Arlt A; Balschun T; Franke A; Lerch MM; Mayerle J; Kratzer W; Boehm BO; Huse K; Schniewind B; Tiemann K; Jiang ZY; Han TQ; Mittal B; Srivastava A; Fenger M; Jørgensen T; Schirin-Sokhan R; Tönjes A; Wittenburg H; Stumvoll M; Kalthoff H; Lammert F; Tepel J; Puschel K; Becker T; Schreiber S; Platzer M; Völzke H; Krawczak M; Miquel JF; Schafmayer C; Hampe J
Hepatology; 2013 Jun; 57(6):2407-17. PubMed ID: 22898925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
